{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:45:27Z","timestamp":1787755527454,"version":"build-2784847793"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thyroid nodules are a very common finding in the general population. Fine-needle aspiration (FNA) has been recommended as the initial test for the evaluation of thyroid nodules. The trend on reporting as atypia of undetermined significance (AUS) has been significantly increased, but the malignant risk is still controversial among different studies. The aim of this study is to investigate the malignancy risk of thyroid nodules reported as Bethesda category III (AUS\/FLUS) on initial FNA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We reviewed 272 papillary thyroid cancer (PTC) patients with suspicious thyroid nodules who underwent fine-needle aspiration and received surgical treatment during 2019 to 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred ten (40.4%) patients were diagnosed with PTC. Multivariate analysis showed that microcalcification (p = 0.037, OR = 2.260, 95% CI: 1.051\u20134.860), shape (p = 0.003, OR = 4.367, 95% CI: 1.629\u201311.705), diameters (p = 0.002, OR = 0.278, 95% CI: 0.123\u20130.631), anti-thyroglobulin antibodies (TGAb) (p = 0.002, OR = 0.150, 95% CI: 0.046\u20130.494), anti-thyroid peroxidase antibody (A-TPO) (p = 0.009, OR = 4.784, 95% CI: 1.486\u201315.401), and nodule goiter (p &amp;lt; 0.001, OR = 0.100, 95% CI: 0.046\u20130.217) were independent malignant risk factors in patients with thyroid nodule classified as Bethesda category III.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, malignant risk factors in patients with thyroid nodule classified as Bethesda category III were significantly associated with preoperative serum TGAb, A-TPO, microcalcification, irregular shape, and nodule diameters. Nodules with malignant factors should be carefully elevated; surgery may be the better option for those patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2021.686849","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T10:25:29Z","timestamp":1631615129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III"],"prefix":"10.3389","volume":"12","author":[{"given":"Jianhao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muye","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1309\/ajcpphlwmi3jv4la","article-title":"The Bethesda System For Reporting Thyroid Cytopathology","volume":"132","author":"Cibas","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda System for Reporting Thyroid Cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/cncy.20178","article-title":"The Atypical Thyroid Fine-Needle Aspiration: Past, Present, and Future","volume":"120","author":"Bongiovanni","year":"2012","journal-title":"Cancer Cytopathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2018-0039","article-title":"Thyroid Cancer Detection Rate and Associated Risk Factors in Patients With Thyroid Nodules Classified as Bethesda Category III","volume":"52","author":"Mileva","year":"2018","journal-title":"Radiol Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3568-y","article-title":"Atypia of Undetermined Significance in Thyroid Fine-Needle Aspiration Cytology: Prediction of Malignancy by US and Comparison of Methods for Further Management","volume":"21","author":"Lee","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2014.86.3.109","article-title":"Atypia of Undetermined Significance on Thyroid Fine Needle Aspiration: Surgical Outcome and Risk Factors for Malignancy","volume":"86","author":"Jung","year":"2014","journal-title":"Ann Surg Treat Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/1066896911415667","article-title":"The Use of the Bethesda Terminology in Thyroid Fine-Needle Aspiration Results in a Lower Rate of Surgery for Nonmalignant Nodules: A Report From a Reference Center in Turkey","volume":"19","author":"Ozluk","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0317","article-title":"Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS\/FLUS)","volume":"24","author":"Ho","year":"2014","journal-title":"Thyroid"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-2990-x","article-title":"Thyroid Nodules With Bethesda System III Cytology: Can Ultrasonography Guide the Next Step","volume":"20","author":"Gweon","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21043","article-title":"Comparison of Cytological Results Obtained by Repeated US-Guided Fine-Needle Aspiration Biopsies of Thyroid Nodules: Focus on the Rate of Malignancy and Diagnostic Concordance","volume":"37","author":"Lee","year":"2009","journal-title":"Diagn Cytopathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000504705","article-title":"Can Repeat Biopsies Change the Prognoses of AUS\/FLUS Nodule","volume":"9","author":"Evranos Ogmen","year":"2020","journal-title":"Eur Thyroid J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2601-2","article-title":"Management of Thyroid Nodules With Atypical Cytology on Fine-Needle Aspiration Biopsy","volume":"20","author":"Nagarkatti","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp031436","article-title":"Clinical Practice. The Thyroid Nodule","volume":"351","author":"Heged\u00fcs","year":"2004","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0992-5","article-title":"How to Approach Thyroid Nodules With Indeterminate Cytology","volume":"17","author":"Yoon","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0353","article-title":"Thyroid Ultrasound Features and Risk of Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies","volume":"25","author":"Remonti","year":"2015","journal-title":"Thyroid"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0052-6","article-title":"Role of Surgeon-Performed Ultrasound in Predicting Malignancy in Patients With Indeterminate Thyroid Nodules","volume":"15","author":"M\u00e9ndez","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0982-x","article-title":"Malignancy is Associated With Microcalcification and Higher AP\/T Ratio in Ultrasonography, But Not With Hashimoto\u2019s Thyroiditis in Histopathology in Patients With Thyroid Nodules Evaluated as Bethesda Category III (AUS\/FLUS) in Cytology","volume":"54","author":"Topaloglu","year":"2016","journal-title":"Endocrine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.surg.2007.08.011","article-title":"Does the Presence of Additional Thyroid Nodules on Ultrasound Alter the Risk of Malignancy in Patients With a Follicular Neoplasm of the Thyroid","volume":"142","author":"Sippel","year":"2007","journal-title":"Surgery"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e7478","DOI":"10.7759\/cureus.7478","article-title":"Thyroid Nodule Size and Prediction of Cancer: A Study at Tertiary Care Hospital in Saudi Arabia","volume":"12","author":"Al-Hakami","year":"2020","journal-title":"Cureus"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2004.07.006","article-title":"Prevalence of Malignancy Within Cytologically Indeterminate Thyroid Nodules","volume":"188","author":"Miller","year":"2004","journal-title":"Am J Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2968","article-title":"Thyroid Nodule Size and Prediction of Cancer","volume":"98","author":"Kamran","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2019.1886","article-title":"Positive Thyroid Antibodies and Risk of Thyroid Cancer: A Systematic Review and Meta-Analysis","volume":"11","author":"Xiao","year":"2019","journal-title":"Mol Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/erc-11-0028","article-title":"Hashimoto's Thyroiditis is Associated With Papillary Thyroid Carcinoma: Role of TSH and of Treatment With L-Thyroxine","volume":"18","author":"Fiore","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23587","article-title":"Thyroid Autoimmunity and Risk of Malignancy in Thyroid Nodules Submitted to Fine-Needle Aspiration Cytology","volume":"37","author":"Grani","year":"2015","journal-title":"Head Neck"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0384","article-title":"Thyroglobulin Antibody is Associated With Increased Cancer Risk in Thyroid Nodules","volume":"20","author":"Kim","year":"2010","journal-title":"Thyroid"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000331088","article-title":"Fine Needle Aspiration Biopsy of Hashimoto's Thyroiditis. Sources of Diagnostic Error","volume":"43","author":"MacDonald","year":"1999","journal-title":"Acta Cytol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/003130299105430","article-title":"Pitfalls in Cytological Diagnosis of Autoimmune Thyroiditis","volume":"31","author":"Kumarasinghe","year":"1999","journal-title":"Pathology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0121-x","article-title":"Coexistence of Thyroglobulin Antibodies and Thyroid Peroxidase Antibodies Correlates With Elevated Thyroid-Stimulating Hormone Level and Advanced Tumor Stage of Papillary Thyroid Cancer","volume":"46","author":"Wu","year":"2014","journal-title":"Endocrine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/ans.12453","article-title":"Anti-Thyroid Antibodies as a Predictor of Thyroid Cancer","volume":"85","author":"Wong","year":"2015","journal-title":"ANZ J Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05153-1","article-title":"Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients With Indeterminate Fine-Needle Aspiration Cytology","volume":"44","author":"Adhami","year":"2020","journal-title":"World J Surg"}],"updated-by":[{"DOI":"10.3389\/fendo.2024.1517690","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.686849\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T03:02:40Z","timestamp":1731639760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.686849\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":30,"alternative-id":["10.3389\/fendo.2021.686849"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.686849","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"article-number":"686849"}}